| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $87K | — |
| R&D Expense | $10.6M | -52.1% |
| SG&A Expense | $5.3M | +16.3% |
| Operating Income | -$15.8M | +40.8% |
| Interest Expense | $16K | +47.5% |
| Pre-tax Income | -$15.7M | +40.6% |
| Net Income | -$15.7M | +40.6% |
| EPS (Basic) | -$0.14 | +70.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.3M | +54.6% |
| Current Assets | $27.7M | +54.1% |
| Total Assets | $28.2M | +51.1% |
| Current Liabilities | $1.4M | +7.7% |
| Stockholders' Equity | $26.5M | +57.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.5M | +20.5% |
| Capital Expenditures | $44K | — |
| Investing Cash Flow | -$44K | — |
| Financing Cash Flow | $23.1M | +41.8% |
| Free Cash Flow | -$13.5M | — |